Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mourez

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Virologie (Montrouge, France)|October 23, 2021
[Human coronaroviruses]A Vabret, T Mourez, J Dina, et al.
Journal of Virological Methods|August 3, 2001
Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reactionA Vabret, F Mouthon, T Mourez, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2018
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)S Lambert-Niclot, M Grude, M L Chaix, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Virologie (Montrouge, France)|October 23, 2021
[Human coronaroviruses]A Vabret, T Mourez, J Dina, et al.
Journal of Virological Methods|August 3, 2001
Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reactionA Vabret, F Mouthon, T Mourez, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2018
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)S Lambert-Niclot, M Grude, M L Chaix, et al.
Pageof 1